Nov 15, 2021 | 2021, Investors, Past Events
Listen to WebcastNov 8, 2021 | 2021, Past Events
Dr. Tobias Weiss, the Principal Investigator of Fibromun’s programs in brain tumors, is presenting an ePoster entitled “Lomustine and targeted-cytokine therapy: a beneficial liaison for recurrent glioblastomaNov 7, 2021 | 2021, Past Events
Philogen is presenting a ePoster on the results of the run-in part of the Phase II study with Fibromun plus Dacarbazine for patients with in third or later line advanced/metastatic soft tissue sarcoma. See here for more details.Nov 6, 2021 | 2021, Past Events
Philogen announces its attendance at the Festival of Biologics Basel on November 10, 2021 Lisa Nadal, 3-year PhD student at Philogen, is giving a lecture entitled “A novel IL12-based immunocytokine targeting Fibroblast Activation Protein (FAP) for the treatment...Nov 5, 2021 | Past Events
Stifel Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a series of one-on-one meetings. Co-founder, CEO and CSO, Prof. Dario Neri is giving a 30 minutes presentation on November 16, 2021...Oct 20, 2021 | 2021, Past Events
Listen to Webcast
Recent Comments